UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 70

Sortiert nach

New pharmacodynamic parameters linked with ibrutinib responses in chronic lymphocytic leukemia: Prospective study in real-world patients and mathematical modeling

PLoS medicine, 2024-07, Vol.21 (7), p.e1004430

2024

Volltextzugriff (PDF)

Somatic genetic alterations predict hematological progression in GATA2 deficiency

Haematologica (Roma), 2023-06, Vol.108 (6), p.1515

2023

Volltextzugriff (PDF)

Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine

PloS one, 2020-10, Vol.15 (10), p.e0238795-e0238795

2020

Volltextzugriff (PDF)

Genomic landscape of hyperleukocytic acute myeloid leukemia

Blood cancer journal (New York), 2022-01, Vol.12 (1), p.4-4, Article 4

2022

Volltextzugriff (PDF)

Longitudinal CITE-Seq profiling of chronic lymphocytic leukemia during ibrutinib treatment: evolution of leukemic and immune cells at relapse

Biomarker research, 2020-12, Vol.8 (1), p.72-72, Article 72

2020

Volltextzugriff (PDF)

Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry study

Blood cancer journal (New York), 2024-05, Vol.14 (1), p.91-10, Article 91

2024

Volltextzugriff (PDF)

Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia

Blood cancer journal (New York), 2022-08, Vol.12 (8), p.117-117, Article 117

2022

Volltextzugriff (PDF)

Acute myeloid leukemia with myelodysplasia-related changes and basophilic differentiation

Blood Research, 2020, 55(3), , pp.130-130

2020

Volltextzugriff (PDF)

CD34 + CD38 - CD123 + Leukemic Stem Cell Frequency Predicts Outcome in Older Acute Myeloid Leukemia Patients Treated by Intensive Chemotherapy but Not Hypomethylating Agents

Cancers, 2020-05, Vol.12 (5), p.1174

2020

Volltextzugriff (PDF)

How to diagnose lymphoplasmacytic lymphoma without infiltration of plasmacytoid lymphocytes?

Blood Research, 2021, 56(3), , pp.125-125

2021

Volltextzugriff (PDF)

Dendrogenin A Synergizes with Cytarabine to Kill Acute Myeloid Leukemia Cells In Vitro and In Vivo

Cancers, 2020-07, Vol.12 (7), p.1725

2020

Volltextzugriff (PDF)

Dismal outcome of refractory or relapsing patients with myelodysplasia‐related acute myeloid leukemia partially alleviated by intensive chemotherapy

Cancer medicine (Malden, MA), 2024-02, Vol.13 (3), p.e7003-n/a

2024

Volltextzugriff (PDF)

When dystrophic plasma cells do not recognize themselves in the mirror

EJHaem, 2020-11, Vol.1 (2), p.408-408

2020

Volltextzugriff (PDF)

Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study

Cancers, 2020-07, Vol.12 (8), p.2044

2020

Volltextzugriff (PDF)

Do not jump to hasty conclusions: all gamma delta T-cells neoplasms are not aggressive

Blood Research, 2019, 54(4), , pp.243-243

2019

Volltextzugriff (PDF)

S162: LOSS OF HEMATOPOIETIC PROGENITORS HETEROGENEITY IS AN ADVERSE PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROMES

HemaSphere, 2023-08, Vol.7 (S3), p.e87989c2

2023

Volltextzugriff (PDF)

Chronic Myeloid Leukaemia with isolated massive thrombocytosis and BCR‐ABL1 detection failure using RT‐MLPA (positive RT‐qPCR)

EJHaem, 2021-08, Vol.2 (3), p.655-656

2021

Volltextzugriff (PDF)

Clonal haematopoiesis is increased in early onset in systemic sclerosis

Rheumatology (Oxford, England), 2020-11, Vol.59 (11), p.3499-3504

2020

Volltextzugriff (PDF)

Diet of neutrophils by bone marrow macrophages in autoimmune neutropenia

Blood, 2021-08, Vol.138 (7), p.584-584

2021

Volltextzugriff (PDF)

Modulation of bone marrow and peripheral blood cytokine levels by age and clonal hematopoiesis in healthy individuals

Clinical immunology (Orlando, Fla.), 2023-10, Vol.255, p.109730-109730, Article 109730

2023

Volltextzugriff (PDF)

Artificial intelligence-based prediction models for acute myeloid leukemia using real-life data: A DATAML registry study

Leukemia research, 2024-01, Vol.136, p.107437-107437, Article 107437

2024

Volltextzugriff (PDF)

Unexplained iron overload with haemolytic anaemia should prompt looking for morphological changes in erythroid precursors

British journal of haematology, 2022-04, Vol.197 (2), p.132-132

2022

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(64)

Publikationsform

Artikel
(66)
Berichte
(4)

Sprache

Englisch
(67)
Koreanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(40)
Hematology
(30)
Humans
(23)
Life Sciences
(19)
Mutation
(19)
Oncology
(16)
Leukemia
(13)
Acute Myeloid Leukemia
(9)
Leukemia, Myeloid, Acute - Genetics
(9)
Bone Marrow
(8)
Chemotherapy
(7)
Female
(7)
Male
(7)
Aged
(6)
Cancer
(6)
Leukemia, Myeloid, Acute - Drug Therapy
(6)
Relapse
(6)
Remission
(6)
Adult
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

New pharmacodynamic parameters linked with ibrutinib responses in chronic lymphocytic leukemia: Prospective study in real-world patients and mathematical modeling

Somatic genetic alterations predict hematological progression in GATA2 deficiency

Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine

Genomic landscape of hyperleukocytic acute myeloid leukemia

Longitudinal CITE-Seq profiling of chronic lymphocytic leukemia during ibrutinib treatment: evolution of leukemic and immune cells at relapse

Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry study

Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia

Acute myeloid leukemia with myelodysplasia-related changes and basophilic differentiation

CD34 + CD38 - CD123 + Leukemic Stem Cell Frequency Predicts Outcome in Older Acute Myeloid Leukemia Patients Treated by Intensive Chemotherapy but Not Hypomethylating Agents

How to diagnose lymphoplasmacytic lymphoma without infiltration of plasmacytoid lymphocytes?

Dendrogenin A Synergizes with Cytarabine to Kill Acute Myeloid Leukemia Cells In Vitro and In Vivo

Dismal outcome of refractory or relapsing patients with myelodysplasia‐related acute myeloid leukemia partially alleviated by intensive chemotherapy

Outcome of Relapsed or Refractory FLT3 -Mutated Acute Myeloid Leukemia Before Second-Generation FLT3 Tyrosine Kinase Inhibitors: A Toulouse-Bordeaux DATAML Registry Study

When dystrophic plasma cells do not recognize themselves in the mirror

Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study

Do not jump to hasty conclusions: all gamma delta T-cells neoplasms are not aggressive

S162: LOSS OF HEMATOPOIETIC PROGENITORS HETEROGENEITY IS AN ADVERSE PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROMES

Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study

Chronic Myeloid Leukaemia with isolated massive thrombocytosis and BCR‐ABL1 detection failure using RT‐MLPA (positive RT‐qPCR)

Clonal haematopoiesis is increased in early onset in systemic sclerosis

Diet of neutrophils by bone marrow macrophages in autoimmune neutropenia

Modulation of bone marrow and peripheral blood cytokine levels by age and clonal hematopoiesis in healthy individuals

UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemia

Artificial intelligence-based prediction models for acute myeloid leukemia using real-life data: A DATAML registry study

Unexplained iron overload with haemolytic anaemia should prompt looking for morphological changes in erythroid precursors

Suchergebnisse filtern